Organon & Co. (OGN) Competitors

Qiagen (NYSE:QGEN) and Organon & Co. (NYSE:OGN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Is QGEN or OGN a better dividend stock?

Qiagen pays an annual dividend of $0.25 per share and has a dividend yield of 0.6%. Organon & Co. pays an annual dividend of $0.08 per share and has a dividend yield of 0.8%. Qiagen pays out 14.8% of its earnings in the form of a dividend. Organon & Co. pays out 3.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Organon & Co. is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do institutionals & insiders have more ownership in QGEN or OGN?

70.0% of Qiagen shares are held by institutional investors. Comparatively, 77.4% of Organon & Co. shares are held by institutional investors. 9.0% of Qiagen shares are held by company insiders. Comparatively, 1.4% of Organon & Co. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media favor QGEN or OGN?

In the previous week, Qiagen had 3 more articles in the media than Organon & Co.. MarketBeat recorded 11 mentions for Qiagen and 8 mentions for Organon & Co.. Organon & Co.'s average media sentiment score of 1.37 beat Qiagen's score of 0.77 indicating that Organon & Co. is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organon & Co.	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate QGEN or OGN?

Qiagen presently has a consensus price target of $49.69, suggesting a potential upside of 9.47%. Organon & Co. has a consensus price target of $17.33, suggesting a potential upside of 66.91%. Given Organon & Co.'s stronger consensus rating and higher probable upside, analysts plainly believe Organon & Co. is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.27
Organon & Co.	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has more risk and volatility, QGEN or OGN?

Qiagen has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, Organon & Co. has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Is QGEN or OGN more profitable?

Qiagen has a net margin of 18.30% compared to Organon & Co.'s net margin of 11.15%. Organon & Co.'s return on equity of 163.88% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	18.30%	14.77%	8.87%
Organon & Co.	11.15%	163.88%	6.99%

Which has preferable earnings & valuation, QGEN or OGN?

Organon & Co. has higher revenue and earnings than Qiagen. Organon & Co. is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.04B	4.95	$83.59M	$1.69	26.86
Organon & Co.	$6.40B	0.42	$864M	$2.69	3.86

Summary

Organon & Co. beats Qiagen on 11 of the 19 factors compared between the two stocks.